Bart Geboers
Impact in
- Biotechnology top 1%
- Microbial Inactivation Methods
- Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
-
- Microbial Inactivation Methods 19
- Hepatology 11
- Hepatocellular Carcinoma Treatment and Prognosis 11
- Co-authors
- Martijn R. MeijerinkHester J. SchefferSanne NieuwenhuizenRobbert S. PuijkAlette H. RuarusTanja D. de GruijlM. Petrousjka van den TolJan J. J. de Vries
- Journals
- Cancers (8 papers)British Journal of Urology (5 papers)Radiology (3 papers)CardioVascular and Interventional Radiology (3 papers)BMC Urology (2 papers)
- Partner nations
- NetherlandsAustraliaUnited Kingdom
In The Last Decade
Bart Geboers
37 papers receiving 1.1k citations
Hit Papers
Peers
Comparison fields: 5 of 85
- Biotechnology 476
- Hepatology 214
- Oncology 356
- Immunology 177
- Radiology, Nuclear Medicine and Imaging 165
Countries citing papers authored by Bart Geboers
This map shows the geographic impact of Bart Geboers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bart Geboers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bart Geboers more than expected).
Fields of papers citing papers by Bart Geboers
This network shows the impact of papers produced by Bart Geboers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bart Geboers. The network helps show where Bart Geboers may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Bart Geboers, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 7 | |
| 2 | 2024 | 4 | |
| 3 | 2023 | 12 | |
| 4 | 2023 | 2 | |
| 5 | 2023 | 1 | |
| 6 | 2022 | 9 | |
| 7 | 2022 | 14 | |
| 8 | 2022 | 10 | |
| 9 | 2022 | 34 | |
| 10 | 2021 | 43 | |
| 11 | 2021 | 30 | |
| 12 | 2021 | 14 | |
| 13 | 2021 | 24 | |
| 14 | 2021 | 26 | |
| 15 | 2021 | 11 | |
| 16 | 2021 | 17 | |
| 17 | 2021 | 8 | |
| 18 | 2021 | 79 | |
| 19 | High-Voltage Electrical Pulses in Oncology: Irreversible Electroporation, Electrochemotherapy, Gene Electrotransfer, Electrofusion, and Electroimmunotherapy Hit paper breakdown → | 2020 | 261 |
| 20 | 2019 | 98 |
About Bart Geboers
Bart Geboers is a scholar working on Biotechnology, Hepatology, Oncology, Pulmonary and Respiratory Medicine and Rheumatology, having authored 38 papers that have together received 1.1k indexed citations. Recurring topics across this work include Microbial Inactivation Methods (19 papers), Hepatocellular Carcinoma Treatment and Prognosis (11 papers), Colorectal Cancer Treatments and Studies (6 papers), Prostate Cancer Diagnosis and Treatment (5 papers), Pancreatic and Hepatic Oncology Research (4 papers), Urologic and reproductive health conditions (4 papers), Prostate Cancer Treatment and Research (4 papers) and MRI in cancer diagnosis (3 papers). The work is most often cited by research in Biotechnology (476 citations), Hepatology (214 citations), Oncology (356 citations), Immunology (177 citations) and Radiology, Nuclear Medicine and Imaging (165 citations). Bart Geboers has collaborated with scholars based in Netherlands, Australia and United Kingdom. Frequent co-authors include Martijn R. Meijerink, Hester J. Scheffer, Sanne Nieuwenhuizen, Robbert S. Puijk, Alette H. Ruarus, Tanja D. de Gruijl, M. Petrousjka van den Tol, Jan J. J. de Vries, Evelien A. C. Schouten and Florentine E. F. Timmer. Their work appears in journals such as Cancers, British Journal of Urology, Radiology, CardioVascular and Interventional Radiology and BMC Urology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.